You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股盤前 | Moderna漲幅擴大至10%
uSMART盈立智投 11-16 20:11

美股抗疫概念股盤前上行。Moderna(MRNA.O)漲8.7%,聯合保健產品漲5.6%,諾瓦瓦克斯醫藥(NVAX.O)漲4.2%,強生(JNJ.N)漲1.8%。

美國藥企Moderna(MRNA.O):計劃在未來幾周內向美國申請新冠疫苗的緊急使用權。美國藥企Moderna(MRNA.O)表示三期試驗疫苗有效性爲94.5%。

對新冠疫苗第三階段研究的分析基於95例病例,其中90例屬於試驗的安慰劑組;11名患有嚴重新冠肺炎的研究參與者都服用了安慰劑。

有望於2021年在全球生產5億至10億劑的新冠疫苗。

BioNTech SE(BNTX.O)美股盤前跌近5%,輝瑞(PFE.N)跌近1%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account